Non-clinical Evaluation of NT-175, an Autologous T Cell Product Engineered to Express an HLA-A*02:01-restricted TCR Targeting TP53 R175H and Resistant to TGF-b Inhibition.Vanessa Tubb,Jennifer Ma, Klaus Buchner,Sander Eshuis,Michelle Mojadidi,Xiang-Jun Kong,Paula Kroon, Arti Sareen, Rojina Duwal,Laura Bies, Julia K. L. Walker,Robbert M. Spaapen,Bas Stringer,Oscar Krijgsman, Helicia Paz-Chang, Yoon-Jung Shin,Thomas Kuilman,Jeroen van Heijst,Gavin Bendle,Arianne PerezJournal of Clinical Oncology（2024）引用 0|浏览4AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
